{"id":"https://openalex.org/W2587999596","doi":"https://doi.org/10.1182/blood.v128.22.578.578","title":"The Preclinical Efficacy of a Novel Telomerase Inhibitor, Imetelstat, in AML - a Randomized Trial in Patient-Derived Xenografts","display_name":"The Preclinical Efficacy of a Novel Telomerase Inhibitor, Imetelstat, in AML - a Randomized Trial in Patient-Derived Xenografts","publication_year":2016,"publication_date":"2016-12-02","ids":{"openalex":"https://openalex.org/W2587999596","doi":"https://doi.org/10.1182/blood.v128.22.578.578","mag":"2587999596"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v128.22.578.578","doi":"https://doi.org/10.1182/blood.v128.22.578.578","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v128.22.578.578","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5004396257","display_name":"Claudia Bruedigam","orcid":"https://orcid.org/0000-0002-9580-1446","observed_orcids":["https://orcid.org/0000-0002-9580-1446"]},"institutions":[{"id":"https://openalex.org/I217937681","display_name":"QIMR Berghofer Medical Research Institute","ror":"https://ror.org/004y8wk30","country_code":"AU","type":"facility","lineage":["https://openalex.org/I217937681"]}],"countries":["AU"],"is_corresponding":true,"raw_author_name":"Claudia Bruedigam","raw_affiliation_strings":["QIMR Berghofer Medical Research Institute, Brisbane, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"QIMR Berghofer Medical Research Institute, Brisbane, Australia","institution_ids":["https://openalex.org/I217937681"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023385833","display_name":"Brad Wackrow","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I217937681","display_name":"QIMR Berghofer Medical Research Institute","ror":"https://ror.org/004y8wk30","country_code":"AU","type":"facility","lineage":["https://openalex.org/I217937681"]}],"countries":["AU"],"is_corresponding":true,"raw_author_name":"Brad Wackrow","raw_affiliation_strings":["QIMR Berghofer Medical Research Institute, Brisbane, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"QIMR Berghofer Medical Research Institute, Brisbane, Australia","institution_ids":["https://openalex.org/I217937681"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011681655","display_name":"Axia Song","orcid":"https://orcid.org/0009-0002-9176-2387","observed_orcids":["https://orcid.org/0009-0002-9176-2387"]},"institutions":[{"id":"https://openalex.org/I217937681","display_name":"QIMR Berghofer Medical Research Institute","ror":"https://ror.org/004y8wk30","country_code":"AU","type":"facility","lineage":["https://openalex.org/I217937681"]}],"countries":["AU"],"is_corresponding":true,"raw_author_name":"Axia Song","raw_affiliation_strings":["QIMR Berghofer Medical Research Institute, Brisbane, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"QIMR Berghofer Medical Research Institute, Brisbane, Australia","institution_ids":["https://openalex.org/I217937681"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Amy H Porter","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I217937681","display_name":"QIMR Berghofer Medical Research Institute","ror":"https://ror.org/004y8wk30","country_code":"AU","type":"facility","lineage":["https://openalex.org/I217937681"]}],"countries":["AU"],"is_corresponding":true,"raw_author_name":"Amy H Porter","raw_affiliation_strings":["QIMR Berghofer Medical Research Institute, Brisbane, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"QIMR Berghofer Medical Research Institute, Brisbane, Australia","institution_ids":["https://openalex.org/I217937681"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066080394","display_name":"Stanley Chun-Wei Lee","orcid":"https://orcid.org/0000-0001-7110-2416","observed_orcids":["https://orcid.org/0000-0001-7110-2416"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Stanley Chun-Wei Lee","raw_affiliation_strings":["Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035808651","display_name":"Andrew S. Moore","orcid":"https://orcid.org/0000-0001-8062-1779","observed_orcids":["https://orcid.org/0000-0001-8062-1779"]},"institutions":[{"id":"https://openalex.org/I1308309334","display_name":"Translational Research Institute","ror":"https://ror.org/00v807439","country_code":"AU","type":"facility","lineage":["https://openalex.org/I1308309334"]},{"id":"https://openalex.org/I165143802","display_name":"The University of Queensland","ror":"https://ror.org/00rqy9422","country_code":"AU","type":"education","lineage":["https://openalex.org/I165143802"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Andrew S. Moore","raw_affiliation_strings":["The University of Queensland Diamantina Institute, The University of Queensland, Brisbane, Australia","Translational Research Institute, Brisbane, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Queensland Diamantina Institute, The University of Queensland, Brisbane, Australia","institution_ids":["https://openalex.org/I165143802"]},{"raw_affiliation_string":"Translational Research Institute, Brisbane, Australia","institution_ids":["https://openalex.org/I1308309334"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025595346","display_name":"Omar Ibrahim Abdel-Wahab","orcid":"https://orcid.org/0000-0002-3907-6171","observed_orcids":["https://orcid.org/0000-0002-3907-6171"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Omar Abdel-Wahab","raw_affiliation_strings":["Memorial Sloan Kettering Cancer Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5084825146","display_name":"Steven Lane","orcid":"https://orcid.org/0000-0002-8050-6209","observed_orcids":["https://orcid.org/0000-0002-8050-6209"]},"institutions":[{"id":"https://openalex.org/I217937681","display_name":"QIMR Berghofer Medical Research Institute","ror":"https://ror.org/004y8wk30","country_code":"AU","type":"facility","lineage":["https://openalex.org/I217937681"]},{"id":"https://openalex.org/I2799393793","display_name":"Royal Brisbane and Women's Hospital","ror":"https://ror.org/05p52kj31","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I1302211766","https://openalex.org/I2799393793","https://openalex.org/I2801244131"]}],"countries":["AU"],"is_corresponding":true,"raw_author_name":"Steven W Lane","raw_affiliation_strings":["QIMR Berghofer Medical Research Institute, Brisbane, Australia","The Royal Brisbane and Women's Hospital, Brisbane, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"QIMR Berghofer Medical Research Institute, Brisbane, Australia","institution_ids":["https://openalex.org/I217937681"]},{"raw_affiliation_string":"The Royal Brisbane and Women's Hospital, Brisbane, Australia","institution_ids":["https://openalex.org/I2799393793"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5004396257","https://openalex.org/A5011681655","https://openalex.org/A5023385833","https://openalex.org/A5066080394","https://openalex.org/A5084825146"],"corresponding_institution_ids":["https://openalex.org/I1334819555","https://openalex.org/I217937681","https://openalex.org/I2799393793"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.6336,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":{"value":0.77345,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":94},"biblio":{"volume":"128","issue":"22","first_page":"578","last_page":"578"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.6211000084877014,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.6211000084877014,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10937","display_name":"Telomeres, Telomerase, and Senescence","score":0.37450000643730164,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/imetelstat","display_name":"imetelstat","score":0.9829999804496765},{"id":"https://openalex.org/keywords/telomerase-inhibitors","display_name":"telomerase inhibitors","score":0.9350000023841858},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.9990000128746033},{"id":"https://openalex.org/keywords/patient-derived-xenografts","display_name":"patient-derived xenografts","score":0.9929999709129333},{"id":"https://openalex.org/keywords/preclinical-efficacy","display_name":"preclinical efficacy","score":0.5249999761581421},{"id":"https://openalex.org/keywords/nod-scid-mouse-model","display_name":"NOD/SCID mouse model","score":0.4819999933242798},{"id":"https://openalex.org/keywords/engraftment","display_name":"engraftment","score":0.6579999923706055},{"id":"https://openalex.org/keywords/survival","display_name":"survival","score":0.44600000977516174},{"id":"https://openalex.org/keywords/heterogeneous-reactions","display_name":"heterogeneous reactions","score":0.4180000126361847},{"id":"https://openalex.org/keywords/oligonucleotide-therapeutics","display_name":"oligonucleotide therapeutics","score":0.5120000243186951},{"id":"https://openalex.org/keywords/translational-research","display_name":"translational research","score":0.31200000643730164},{"id":"https://openalex.org/keywords/patient-selection-for-clinical-trials","display_name":"patient selection for clinical trials","score":0.4320000112056732},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.5320000052452087},{"id":"https://openalex.org/keywords/measurable-residual-disease","display_name":"minimal residual disease","score":0.3529999852180481}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7635178565979004},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.5446460247039795},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5372519493103027},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.4731653332710266},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.42767399549484253},{"id":"https://openalex.org/C2780076729","wikidata":"https://www.wikidata.org/wiki/Q1752571","display_name":"Myelofibrosis","level":3,"score":0.4184392988681793},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.38883355259895325},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3561325669288635},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v128.22.578.578","doi":"https://doi.org/10.1182/blood.v128.22.578.578","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v128.22.578.578","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3150347982","https://openalex.org/W2979988239","https://openalex.org/W3213426163","https://openalex.org/W4220976680","https://openalex.org/W4405045799","https://openalex.org/W4404462802","https://openalex.org/W4405041381","https://openalex.org/W2594805696","https://openalex.org/W2669821550","https://openalex.org/W4388033937"],"abstract_inverted_index":{"Abstract":[0],"Replicative":[1],"immortality":[2],"depends":[3],"on":[4,198,397,614],"telomerase":[5,27],"activation":[6],"in":[7,37,48,54,185,277,288,297,326,410,578,607,623,649],"the":[8,44,152,179,289,395,449,452,534,624,642],"majority":[9],"of":[10,31,46,91,115,128,181,312,323,377,451,582,588,630,647],"cancers":[11],"including":[12],"acute":[13],"myeloid":[14,535,631],"leukemia":[15],"(AML).":[16],"Imetelstat":[17,177,314],"is":[18,638],"a":[19,51,579],"covalently":[20],"lipidated":[21],"13-mer":[22],"oligonucleotide":[23],"that":[24],"competitively":[25],"inhibits":[26],"activity.":[28],"Clinical":[29],"efficacy":[30,45,127,577,646],"imetelstat":[32,47,138,429,575,597,648],"has":[33],"recently":[34],"been":[35],"reported":[36],"essential":[38],"thrombocythemia":[39],"and":[40,93,112,135,243,283,302,310,321,442,490,496,605,620,632,644],"myelofibrosis.":[41],"We":[42],"investigated":[43],"AML":[49,61,75,119,183,189,213,221,263,327,335,359,583,591],"using":[50],"randomized":[52,134],"trial":[53],"patient-derived":[55],"xenografts":[56],"(PDX).":[57],"To":[58,393],"establish":[59],"an":[60],"PDX":[62,162,187,264,584],"cohort,":[63,154],"primary":[64],"bone":[65],"marrow":[66],"(BM)":[67],"or":[68,103,143,208,217,430,539],"peripheral":[69],"blood":[70,403],"(PB)":[71],"samples":[72,121,191],"from":[73,433],"31":[74],"patients":[76],"were":[77,124,133,192,285,426,445,493,500,598,618],"transplanted":[78,405],"into":[79,194,406],"NOD.Cg":[80],"Prkdcscid":[81],"Il2rgtm1Wjl":[82],"Tg":[83],"(CMV-IL3,CSF2,KITLG)1Eav/Mlo":[84],"(NSGS).":[85],"Engraftment":[86,414],"was":[87,110,113,156,316,382,404,415,456,537],"defined":[88],"by":[89,421],"reconstitution":[90],"BM":[92,440],"spleen":[94,497,504,518,544,558],"with":[95,137,318,385,428,600,627],"CD33+":[96],"donor":[97,443,471,516,556],"cells,":[98],"PB":[99,422,495],"circulating":[100],"blasts,":[101],"anemia":[102],"thrombocytopenia.":[104],"The":[105,375,612],"success":[106],"rate":[107],"for":[108,126,158,660],"engraftment":[109,444,499],"70.4%":[111],"independent":[114,118],"cytogenetics.":[116],"Fifteen":[117],"patient":[120,190,214,222,336,592],"(n=12":[122],"recipients/sample)":[123],"tested":[125],"imetelstat.":[129],"After":[130,436],"engraftment,":[131],"mice":[132],"treated":[136,427],"(15":[139],"mg/kg":[140],"body":[141],"weight)":[142],"control":[144,432],"phosphate-buffered":[145],"saline":[146],"(PBS)":[147],"intraperitoneally":[148],"every":[149],"48-72h.":[150],"Across":[151],"entire":[153],"survival":[155,199,205],"improved":[157],"imetelstat-":[159],"vs.":[160],"PBS-treated":[161],"(Hazard":[163],"ratio":[164],"PBS:":[165,343,361,460,473,505,519,545,559],"5.299;":[166],"3.379":[167],"\u00b1":[168,345,349,363,367,462,466,475,479,507,511,521,525,547,551,561,565],"8.312;":[169],"p":[170,252,351,369,468,481,513,527,553,567],"<":[171,352,370,514,554],"0.0001;":[172],"Cox":[173],"proportional":[174],"hazards":[175],"model).":[176],"delayed":[178],"expansion":[180],"human":[182,399,616],"cells":[184],"14":[186],"(93.3%).":[188],"divided":[193],"2":[195,411,472,517,557],"groups":[196,604],"based":[197],"outcomes,":[200],"\"Sustained":[201],"responders\"":[202,219],"(imetelstat":[203],"extended":[204],">":[206,209],"2-fold":[207],"4":[210,418,434],"weeks;":[211],"9":[212,586],"samples;":[215],"60%)":[216],"\"Poor":[218],"(6":[220],"samples,":[223],"40%).":[224],"European":[225],"LeukemiaNet":[226],"(ELN)-karyotypic":[227],"subtypes":[228],"differed":[229],"trend-wise":[230],"between":[231],"groups:":[232],"favourable":[233,601],"(100%":[234],"sustained,":[235,246],"0%":[236],"poor":[237,244,248],"response":[238,249,315,386],"to":[239,250,341,596,640],"imetelstat);":[240],"intermediate-1,":[241],"intermediate-2":[242],"(45.5%":[245],"54.5%":[247],"imetelstat;":[251],"=":[253,388,469,482,528,568],"0.1,":[254],"Fisher's":[255,390],"exact":[256,391],"test).":[257,374,392,486,572],"Next":[258],"generation":[259],"sequencing":[260],"revealed":[261,295],"baseline":[262],"genetic":[265],"profiles.":[266],"FLT3,":[267],"NRAS,":[268],"TET2,":[269],"RAD21":[270],"as":[271,273],"well":[272],"15":[274,589],"genes":[275,305],"annotated":[276],"DNA":[278,610],"damage,":[279],"cell":[280,488,634],"cycle":[281,489],"regulation":[282],"apoptosis":[284],"mutated":[286],"exclusively":[287],"sustained":[290],"responders":[291,294],"group.":[292],"Poor":[293],"mutations":[296,379,606],"ETV6,":[298],"FANCM,":[299],"MKI67,":[300],"WT1":[301],"16":[303],"additional":[304],"regulating":[306],"growth":[307],"factor":[308],"independence":[309],"evasion":[311],"apoptosis.":[313],"associated":[317,599],"reduced":[319,447,501],"quiescence":[320,357],"induction":[322],"\u03b3-H2AX":[324,338,491],"levels":[325,492],"populations":[328],"(n=4-6":[329],"/":[330,332],"group":[331],"3":[333],"individual":[334,590],"samples):":[337],"(MFI":[339],"normalized":[340],"PBS;":[342],"1.0":[344],"0.02;":[346,350],"imetelstat:":[347,365,464,477,509,523,549,563],"1.24":[348],"0.0001,":[353],"Student's":[354,372,484,530,570],"t":[355,373,485,531,571],"test),":[356,532],"(%Ki67-diploid":[358],"cells;":[360],"11.62%":[362],"0.87;":[364],"6.9%":[366],"0.68;":[368],"0.001,":[371],"presence":[376],"spliceosome":[378],"(SRSF2,":[380],"U2AF1)":[381],"not":[383],"correlated":[384],"(p":[387],"0.5;":[389],"investigate":[394],"effects":[396,613],"normal":[398,615],"hematopoiesis,":[400],"CD34-enriched":[401],"cord":[402],"NOD.Cg-PrkdcscidIl2rgtm1Wjl/SzJ":[407],"(NSG,":[408],"n=5-6/group/donor":[409],"replicate":[412],"experiments).":[413],"confirmed":[416],"at":[417],"weeks":[419,438],"post-transplant":[420],"chimerism":[423],"(>=1%).":[424],"Mice":[425],"vehicle":[431],"weeks.":[435],"10":[437],"treatment,":[439],"cellularity":[441],"significantly":[446],"whereas":[448,533],"frequency":[450],"CD34+CD38low":[453],"HSC-enriched":[454],"population":[455],"unchanged":[457],"(donor":[458,502,542],"1":[459,503,543],"0.35%":[461],"0.03%,":[463],"0.23%":[465],"0.06%,":[467],"0.1;":[470],"0.45%":[474],"0.05%,":[476],"0.92%":[478],"0.35%,":[480],"0.2,":[483],"HSC":[487],"unchanged.":[494],"B-cell":[498],"77.74%":[506],"4.66%,":[508],"45.48%":[510],"9.03%,":[512],"0.05;":[515,555],"93.95%":[520],"0.40%,":[522],"89.1%":[524],"2.52%,":[526],"0.09,":[529],"lineage":[536,626],"elevated":[538],"relatively":[540],"preserved":[541],"3.29%":[546],"0.71%,":[548],"7.53%":[550],"1.6%,":[552],"1.20%":[560],"0.12%,":[562],"4.49%":[564],"1.60%,":[566],"0.07,":[569],"In":[573],"summary,":[574],"demonstrates":[576],"significant":[580],"proportion":[581],"(60%,":[585],"out":[587],"samples).":[593],"Robust":[594],"responses":[595],"cytogenetic":[602],"risk":[603],"pathways":[608],"controlling":[609],"damage.":[611],"hematopoiesis":[617],"modest":[619],"predominantly":[621],"seen":[622],"B-lymphocyte":[625],"relative":[628],"preservation":[629],"stem":[633],"populations.":[635],"Further":[636],"study":[637],"warranted":[639],"understand":[641],"preclinical":[643],"clinical":[645],"AML.":[650],"Disclosures":[651],"Lane:":[652],"Janssen:":[653],"Other:":[654],"i":[655],"have":[656],"done":[657],"consulting":[658],"(once)":[659],"janssen..":[661]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":1}],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2017-02-24T00:00:00"}